Efficacy and Safety of Rifaximin Treatment for Reducing the Risk of Overt Hepatic Encephalopathy by Baseline Hepatic Impairment

被引：0
|
作者：
Flamm, Steven L. [1 ]
Bajaj, Jasmohan S. [2 ,3 ]
Heimanson, Zeev [4 ]
Neff, Guy [5 ]
机构：
[1] Northwestern Feinberg, Sch Med, Chicago, IL USA
[2] Virginia Commonwealth Univ, Richmond, VA USA
[3] McGuire VA Med Ctr, Richmond, VA USA
[4] Salix Pharmaceut, Bridgewater, NJ USA
[5] Florida Digest Hlth Specialists, Florida Res Inst, Lakewood Ranch, FL USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2018年 / 113卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
829
引用
收藏
页码：S458 / S460
页数：3
相关论文
共 50 条
  • [1] EFFICACY AND SAFETY OF RIFAXIMIN TREATMENT FOR REDUCING THE RISK OF OVERT HEPATIC ENCEPHALOPATHY BY BASELINE HEPATIC IMPAIRMENT
    Flamm, Steven L.
    Bajaj, Jasmohan S.
    Heimanson, Zeev
    Neff, Guy
    GASTROENTEROLOGY, 2019, 156 (06) : S113 - S113
  • [2] EFFICACY OF RIFAXIMIN VERSUS LACTULOSE FOR REDUCING THE RECURRENCE OF OVERT HEPATIC ENCEPHALOPATHY AND HOPITALIZATIONS IN CIRRHOSIS
    Irimia, Roxana
    Trifan, Anca
    MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA, 2012, 116 (04): : 1021 - 1027
  • [3] Safety and efficacy of rifaximin in the treatment of hepatic encephalopathy in liver cirrhosis.
    Lata, J
    Hulek, P
    Spicak, J
    Fejfar, T
    Drastich, P
    Marecek, Z
    Bruha, R
    Husova, L
    Senkyrik, M
    HEPATOLOGY, 2002, 36 (04) : 519A - 519A
  • [4] The efficacy and safety of rifaximin-a: a 2-year observational study of overt hepatic encephalopathy
    Oey, Rosalie
    Buck, Lennart E. M.
    Erler, Nicole
    Van Buuren, Henk
    De Man, Robert
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E668 - E668
  • [5] The efficacy and safety of rifaximin-α: a 2-year observational study of overt hepatic encephalopathy
    Oey, Rosalie C.
    Buck, Lennart E. M.
    Erler, Nicole S.
    van Buuren, Henk R.
    de Man, Robert A.
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2019, 12
  • [6] EFFICACY OF RIFAXIMIN IN HEPATIC ENCEPHALOPATHY
    Zafar, Muneeba
    Iqbal, Muhammad Asim
    Qaiser, Luqman
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 6 (05): : 10325 - 10329
  • [7] Safety, efficacy, and patient acceptability of rifaximin for hepatic encephalopathy
    Kimer, Nina
    Krag, Aleksander
    Gluud, Lise L.
    PATIENT PREFERENCE AND ADHERENCE, 2014, 8 : 331 - 338
  • [8] Rifaximin: A Review of Its Use in Reducing Recurrence of Overt Hepatic Encephalopathy Episodes
    Lesley J. Scott
    Drugs, 2014, 74 : 2153 - 2160
  • [9] Rifaximin: A Review of Its Use in Reducing Recurrence of Overt Hepatic Encephalopathy Episodes
    Scott, Lesley J.
    DRUGS, 2014, 74 (18) : 2153 - 2160
  • [10] The Long Term Efficacy and Safety of Rifaximin in the Maintenance of Remission From Overt Hepatic Encephalopathy in Cirrhotic Patients
    Mullen, Kevin D.
    Sanyal, Arun J.
    Bass, Nathan M.
    Poordad, Fred
    Huang, Shirley
    Merchant, Kunal
    Bortey, Enoch
    Forbes, William P.
    GASTROENTEROLOGY, 2012, 142 (05) : S41 - S42
12345